Literature DB >> 18323444

An oncogene-induced DNA damage model for cancer development.

Thanos D Halazonetis1, Vassilis G Gorgoulis, Jiri Bartek.   

Abstract

Of all types of DNA damage, DNA double-strand breaks (DSBs) pose the greatest challenge to cells. One might have, therefore, anticipated that a sizable number of DNA DSBs would be incompatible with cell proliferation. Yet recent experimental findings suggest that, in both precancerous lesions and cancers, activated oncogenes induce stalling and collapse of DNA replication forks, which in turn leads to formation of DNA DSBs. This continuous formation of DNA DSBs may contribute to the genomic instability that characterizes the vast majority of human cancers. In addition, in precancerous lesions, these DNA DSBs activate p53, which, by inducing apoptosis or senescence, raises a barrier to tumor progression. Breach of this barrier by various mechanisms, most notably by p53 mutations, that impair the DNA damage response pathway allows cancers to develop. Thus, oncogene-induced DNA damage may explain two key features of cancer: genomic instability and the high frequency of p53 mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323444     DOI: 10.1126/science.1140735

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  846 in total

1.  Three-dimensionally specific inhibition of DNA repair-related genes by activated KRAS in colon crypt model.

Authors:  Toshiyuki Tsunoda; Yasuo Takashima; Takahiro Fujimoto; Midori Koyanagi; Yasuhiro Yoshida; Keiko Doi; Yoko Tanaka; Masahide Kuroki; Takehiko Sasazuki; Senji Shirasawa
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

Review 2.  Using mice to examine p53 functions in cancer, aging, and longevity.

Authors:  Lawrence A Donehower
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11-04       Impact factor: 10.005

3.  The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.

Authors:  Thuy-Ai Nguyen; Scott D Slattery; Sung-Hwan Moon; Yolanda F Darlington; Xiongbin Lu; Lawrence A Donehower
Journal:  DNA Repair (Amst)       Date:  2010-05-06

4.  Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability.

Authors:  Katrine B V Greve; Jonas N Lindgreen; Mikkel G Terp; Christina B Pedersen; Steffen Schmidt; Jan Mollenhauer; Stine B Kristensen; Rikke S Andersen; Mette M Relster; Henrik J Ditzel; Morten F Gjerstorff
Journal:  Mol Oncol       Date:  2014-10-06       Impact factor: 6.603

5.  Nucleoporin NUP153 guards genome integrity by promoting nuclear import of 53BP1.

Authors:  P Moudry; C Lukas; L Macurek; B Neumann; J-K Heriche; R Pepperkok; J Ellenberg; Z Hodny; J Lukas; J Bartek
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

6.  DNA damage response signaling triggers nuclear localization of the chicken anemia virus protein Apoptin.

Authors:  Thomas J Kucharski; Isabelle Gamache; Ole Gjoerup; Jose G Teodoro
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

7.  Endogenous DNA replication stress results in expansion of dNTP pools and a mutator phenotype.

Authors:  Marta B Davidson; Yuki Katou; Andrea Keszthelyi; Tina L Sing; Tian Xia; Jiongwen Ou; Jessica A Vaisica; Neroshan Thevakumaran; Lisette Marjavaara; Chad L Myers; Andrei Chabes; Katsuhiko Shirahige; Grant W Brown
Journal:  EMBO J       Date:  2012-01-10       Impact factor: 11.598

8.  Thresholds of replication stress signaling in cancer development and treatment.

Authors:  Jiri Bartek; Martin Mistrik; Jirina Bartkova
Journal:  Nat Struct Mol Biol       Date:  2012-01-05       Impact factor: 15.369

Review 9.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

10.  Wild-type RAS: keeping mutant RAS in CHK.

Authors:  Theonie Anastassiadis; Eric J Brown
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.